Multi-furcated Drug Allocation System for 340B Compliance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Covered entities face challenges in complying with stringent regulations of drug discount programs, such as the 340B program, due to difficulties in linking drug purchases from distributors to specific dispensations and maintaining accurate auditing records, especially when proprietary codes do not have a one-to-one mapping with standardized drug identification codes.
Innovation Solution
A system and method that processes dispensation data to map proprietary codes to standardized drug identification codes, creates audit records, and applies reorder rules to determine when to reorder drugs, ensuring compliance with drug discount programs by linking purchases to dispensations and managing inventory levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If proprietary codes are used for drug identification in dispensation data, then the covered entity can maintain its own drug identification system, but the codes cannot be directly linked to standardized drug identification codes for auditing purposes
Solution Approach 1:
The patent introduces an intermediary mapping system that connects proprietary drug codes to standardized NDC codes through audit records. This intermediary layer allows the covered entity to maintain its proprietary coding system while enabling reliable linkage to standardized codes for compliance auditing, thus resolving the contradiction between system adaptability and audit reliability.
Solution Approach 2:
The patent replaces the direct mechanical linkage requirement between proprietary codes and standardized codes with a data-driven substitution approach. Instead of requiring direct one-to-one correspondence, the system uses audit records containing both code types to establish logical connections, enabling compliance verification without direct code mapping.
2Adaptability or versatility
If multiple audit records exist for a single standardized drug code, then the system can track different pricing accounts separately, but it becomes difficult to determine which audit record to allocate dispensed quantities to
Solution Approach 1:
The patent implements dynamic allocation logic that automatically determines which audit record receives dispensed quantities based on real-time conditions such as current inventory levels, dispensation dates, and pricing account eligibility. This dynamic approach allows the system to handle multiple pricing accounts flexibly while maintaining ease of operation through automated decision-making rules.
Solution Approach 2:
The patent applies preliminary allocation rules that pre-determine how dispensed quantities should be distributed across multiple audit records before actual dispensation occurs. By establishing allocation priorities and rules in advance, the system simplifies the operational complexity of managing multiple pricing accounts while ensuring proper tracking for compliance purposes.
3Reliability
If the system tracks detailed dispensation data for compliance auditing, then eligibility for discounted pricing can be verified, but the complexity of maintaining accurate records increases
Solution Approach 1:
The patent creates a universal audit record structure that serves multiple functions simultaneously: tracking dispensation data for compliance verification, managing inventory levels, determining reorder timing, and maintaining pricing account associations. This multi-functional design reduces overall system complexity while ensuring reliable compliance verification through a single integrated record-keeping mechanism.
Data Source
AI summary
Example embodiments are disclosed for receiving dispensation data corresponding to dispensation of a drug associated with a covered entity, mapping a proprietary code to a standardized drug identification code for the drug, retrieving an audit record based on the standardized code, wherein the audit record identifies an order quantity of the drug ordered by the covered entity using a pricing account, allocating the dispensed quantity of the drug to the audit record up to an amount that equals but does not exceed the order quantity, applying a reorder rule to calculate when to reorder the drug, and subsequent to determining to reorder the drug in response to applying the reorder rule, communicating to a distributor an order message comprising the order quantity and the standardized code of the drug to reorder the drug using the pricing account and for causing the distributor to ship the drug.